Collateral hypersensitivity between ZY19489 and piperaquine neutralizes PfCRT-mediated drug efflux and Plasmodium falciparum resistance

preprint OA: closed
Full text JSON View at publisher
Full text 21,035 characters · extracted from preprint-html · click to expand
Collateral hypersensitivity between ZY19489 and piperaquine neutralizes PfCRT-mediated drug efflux and Plasmodium falciparum resistance | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Article Collateral hypersensitivity between ZY19489 and piperaquine neutralizes PfCRT-mediated drug efflux and Plasmodium falciparum resistance David Fidock, John Okombo, Tolla Ndiaye, Tarrick Qahash, Igor Moura, and 24 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-7697517/v1 This work is licensed under a CC BY 4.0 License Status: Under Review Version 1 posted You are reading this latest preprint version Abstract New antimalarial drugs are essential to combat the current emergence and spread of Plasmodium falciparum parasite resistance to first-line artemisinin-based combination therapies. Here, we identify a mechanism of parasite resistance to ZY19489, a triaminopyrimidine currently in a Phase IIb clinical trial. Low-grade resistance was mediated by a novel mutation in the P. falciparum chloroquine resistance transporter PfCRT, which caused a major reduction in asexual blood stage parasite growth rates and a substantial fitness cost. Parasites resistant to ZY19489 lost their chloroquine resistance status and became hypersusceptible to the artemisinin-based combination partner drug piperaquine. All three agents were shown to interfere with parasite-mediated catabolism of host hemoglobin. Uptake studies in PfCRT-containing proteoliposomes provide evidence that ZY19489 can block mutant PfCRT-mediated efflux of piperaquine and chloroquine, creating a scenario of an evolutionary trap whereby resistance to ZY19489 blocks PfCRT efflux-mediated resistance and restores susceptibility to piperaquine and chloroquine. Metabolomic studies revealed that ZY19489 significantly reduces intracellular levels of short hemoglobin-derived peptides (a natural substrate of PfCRT) and leads to higher accumulation of pyrimidine deoxynucleotides. Our data present a marker for tracking the evolution of clinical resistance to ZY19489 and a rationale for pairing this with piperaquine to generate a novel resistance-refractory combination. Biological sciences/Microbiology/Parasitology/Parasite biology Biological sciences/Chemical biology/Mechanism of action Full Text Additional Declarations There is NO Competing Interest. Supplementary Files OkomboZY19489SupplementaryMaterial.docx Supplementary Figures and Tables Cite Share Download PDF Status: Under Review Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-7697517","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Article","associatedPublications":[],"authors":[{"id":526461761,"identity":"63a51331-1579-4d0f-97a2-5a34b640b377","order_by":0,"name":"David Fidock","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAA/0lEQVRIiWNgGAWjYDCCw4cPPvhgYAPjWjAwSDA2ABnMuLUcS0s2nFGRBuNKEKMlx0ya48xhZC1gBm4tfMcYDKQZ287LG1w7/IDhR4VE4trZzY0fGCqsExtwaJE8xpBgXNh223DD7TQDxp4zEonb7hxslmA4k45Ti8H9hgPJM9tuJxjczmFgZmwDarmR2CDB2HYYt5ZjjA2HedvOoWhp/sH4D58WZsZmnjMHULS0AQMNtxbJY2zMjDMqkg1nAv1yEOgXY6Bf2iwSjqUb49LCd4z/+48PBnbyfLeTHz74UWEju+12++MbH2qsZXFpQQEH4KwEYpSPglEwCkbBKMAJAArsZPKFBvkxAAAAAElFTkSuQmCC","orcid":"https://orcid.org/0000-0001-6753-8938","institution":"Columbia University Irving Medical Center","correspondingAuthor":true,"prefix":"","firstName":"David","middleName":"","lastName":"Fidock","suffix":""},{"id":526461762,"identity":"da5c8dbb-696f-40aa-9d06-fd55d48ab10c","order_by":1,"name":"John Okombo","email":"","orcid":"https://orcid.org/0000-0001-8680-2351","institution":"Columbia University Irving Medical Center","correspondingAuthor":false,"prefix":"","firstName":"John","middleName":"","lastName":"Okombo","suffix":""},{"id":526461763,"identity":"a28d43b5-a072-4871-aaf6-77270085ecfb","order_by":2,"name":"Tolla Ndiaye","email":"","orcid":"","institution":"Columbia University Irving Medical Center","correspondingAuthor":false,"prefix":"","firstName":"Tolla","middleName":"","lastName":"Ndiaye","suffix":""},{"id":526461764,"identity":"e9e67c4e-941d-4a95-a1ad-7644abba0e6c","order_by":3,"name":"Tarrick Qahash","email":"","orcid":"","institution":"The Pennsylvania State University","correspondingAuthor":false,"prefix":"","firstName":"Tarrick","middleName":"","lastName":"Qahash","suffix":""},{"id":526461765,"identity":"e36b2e35-deb2-4c8d-92b6-6be05f552f9c","order_by":4,"name":"Igor Moura","email":"","orcid":"https://orcid.org/0000-0003-3279-6894","institution":"Columbia University Irving Medical Center","correspondingAuthor":false,"prefix":"","firstName":"Igor","middleName":"","lastName":"Moura","suffix":""},{"id":526461766,"identity":"159f4b1c-13ab-44a4-85c2-d929d9bd7269","order_by":5,"name":"Eva Gil-Iturbe","email":"","orcid":"https://orcid.org/0000-0002-4046-5756","institution":"Columbia University Irving Medical Center","correspondingAuthor":false,"prefix":"","firstName":"Eva","middleName":"","lastName":"Gil-Iturbe","suffix":""},{"id":526461767,"identity":"c8997df3-2de4-48d1-aa3b-b71d51f9f717","order_by":6,"name":"Laura Hagenah","email":"","orcid":"","institution":"Columbia University Irving Medical Center","correspondingAuthor":false,"prefix":"","firstName":"Laura","middleName":"","lastName":"Hagenah","suffix":""},{"id":526461768,"identity":"5e3a458f-06c3-4182-989e-76e9a83c7146","order_by":7,"name":"Jessica Bridgford","email":"","orcid":"","institution":"Columbia University Irving Medical Center","correspondingAuthor":false,"prefix":"","firstName":"Jessica","middleName":"","lastName":"Bridgford","suffix":""},{"id":526461769,"identity":"9c587a9f-0392-4093-95f5-8db19a01e6f9","order_by":8,"name":"Vinicius Bonatto","email":"","orcid":"","institution":"University of São Paulo","correspondingAuthor":false,"prefix":"","firstName":"Vinicius","middleName":"","lastName":"Bonatto","suffix":""},{"id":526461770,"identity":"8eca901d-2bf9-48ef-9cb0-5df52f553c54","order_by":9,"name":"Kurt Ward","email":"","orcid":"","institution":"Columbia University Irving Medical Center","correspondingAuthor":false,"prefix":"","firstName":"Kurt","middleName":"","lastName":"Ward","suffix":""},{"id":526461771,"identity":"88ba629f-6be1-407b-9a55-de9ef905d4a0","order_by":10,"name":"Tomas Yeo","email":"","orcid":"https://orcid.org/0000-0003-2923-6060","institution":"Columbia University Medical Center","correspondingAuthor":false,"prefix":"","firstName":"Tomas","middleName":"","lastName":"Yeo","suffix":""},{"id":526461772,"identity":"bad3a4aa-bd0a-4322-87f9-54f828d365da","order_by":11,"name":"Sunil Narwal","email":"","orcid":"https://orcid.org/0000-0001-5476-9753","institution":"Columbia University Irving Medical Center","correspondingAuthor":false,"prefix":"","firstName":"Sunil","middleName":"","lastName":"Narwal","suffix":""},{"id":526461773,"identity":"360241e5-ebb9-459b-8b9d-0214d351f1db","order_by":12,"name":"Lily Orta","email":"","orcid":"https://orcid.org/0009-0009-0432-8955","institution":"Columbia University Irving Medical Center","correspondingAuthor":false,"prefix":"","firstName":"Lily","middleName":"","lastName":"Orta","suffix":""},{"id":526461774,"identity":"0a3c6004-16d0-4742-9a3a-8756a27ce716","order_by":13,"name":"Isla Anderson","email":"","orcid":"","institution":"Columbia University Irving Medical Center","correspondingAuthor":false,"prefix":"","firstName":"Isla","middleName":"","lastName":"Anderson","suffix":""},{"id":526461775,"identity":"4901c74e-9e87-4a3e-9b3f-ba65b0443556","order_by":14,"name":"Satish Kumar Dhingra","email":"","orcid":"","institution":"Columbia University Medical Center","correspondingAuthor":false,"prefix":"","firstName":"Satish","middleName":"Kumar","lastName":"Dhingra","suffix":""},{"id":526461776,"identity":"8c6481f6-ba5a-4352-a1af-b6f271d6f29a","order_by":15,"name":"Charisse Pasaje","email":"","orcid":"","institution":"Massachusetts Institute of Technology","correspondingAuthor":false,"prefix":"","firstName":"Charisse","middleName":"","lastName":"Pasaje","suffix":""},{"id":526461777,"identity":"f30d98d0-59cc-4d84-a868-a099fa46977d","order_by":16,"name":"Heekuk Park","email":"","orcid":"https://orcid.org/0000-0001-5815-9717","institution":"Columbia University","correspondingAuthor":false,"prefix":"","firstName":"Heekuk","middleName":"","lastName":"Park","suffix":""},{"id":526461778,"identity":"4f878fb7-378d-4cc9-bdd3-72a4604d7214","order_by":17,"name":"Jonathan Kim","email":"","orcid":"","institution":"Columbia University","correspondingAuthor":false,"prefix":"","firstName":"Jonathan","middleName":"","lastName":"Kim","suffix":""},{"id":526461779,"identity":"54fe8f63-6d97-467b-acc3-3a5a74ba8114","order_by":18,"name":"Rafael Guido","email":"","orcid":"https://orcid.org/0000-0002-7187-0818","institution":"University of Sao Paulo","correspondingAuthor":false,"prefix":"","firstName":"Rafael","middleName":"","lastName":"Guido","suffix":""},{"id":526461780,"identity":"586ead44-3e76-409b-863b-ba30507618a6","order_by":19,"name":"Iñigo Angulo-Barturen","email":"","orcid":"https://orcid.org/0000-0002-8800-8132","institution":"The Art of Discovery, SL","correspondingAuthor":false,"prefix":"","firstName":"Iñigo","middleName":"","lastName":"Angulo-Barturen","suffix":""},{"id":526461781,"identity":"1de6c572-25d9-4070-b0b2-a37294f601e2","order_by":20,"name":"Jacquin Niles","email":"","orcid":"https://orcid.org/0000-0002-6250-8796","institution":"Massachusetts Institute of Technology","correspondingAuthor":false,"prefix":"","firstName":"Jacquin","middleName":"","lastName":"Niles","suffix":""},{"id":526461782,"identity":"be07714e-db4f-42ab-a056-23ccc3a266d7","order_by":21,"name":"Filippo Mancia","email":"","orcid":"","institution":"","correspondingAuthor":false,"prefix":"","firstName":"Filippo","middleName":"","lastName":"Mancia","suffix":""},{"id":526461783,"identity":"a427416a-b573-4afb-b13b-0e671e4e4940","order_by":22,"name":"Anne-Catrin Uhlemann","email":"","orcid":"https://orcid.org/0000-0002-9798-4768","institution":"Columbia University","correspondingAuthor":false,"prefix":"","firstName":"Anne-Catrin","middleName":"","lastName":"Uhlemann","suffix":""},{"id":526461784,"identity":"2b1d8c80-40bc-45ca-bb01-ee6c55bb6049","order_by":23,"name":"Sachel Mok","email":"","orcid":"https://orcid.org/0000-0002-9605-0154","institution":"Columbia University Medical Center","correspondingAuthor":false,"prefix":"","firstName":"Sachel","middleName":"","lastName":"Mok","suffix":""},{"id":526461785,"identity":"653ae725-f9ca-42a7-ac23-e2d74c3d39e5","order_by":24,"name":"Matthias Quick","email":"","orcid":"https://orcid.org/0000-0002-8620-827X","institution":"Columbia University","correspondingAuthor":false,"prefix":"","firstName":"Matthias","middleName":"","lastName":"Quick","suffix":""},{"id":526461786,"identity":"c1504ff1-76f0-4c60-85eb-34d2b9b33170","order_by":25,"name":"Elizabeth Winzeler","email":"","orcid":"https://orcid.org/0000-0002-4049-2113","institution":"University of California, San Diego","correspondingAuthor":false,"prefix":"","firstName":"Elizabeth","middleName":"","lastName":"Winzeler","suffix":""},{"id":526461787,"identity":"571a3433-ecdb-45ce-bda1-2aa1d8efa016","order_by":26,"name":"Didier Leroy","email":"","orcid":"https://orcid.org/0000-0002-5594-3204","institution":"Medicines for Malaria Venture","correspondingAuthor":false,"prefix":"","firstName":"Didier","middleName":"","lastName":"Leroy","suffix":""},{"id":526461788,"identity":"09633312-70be-4131-8a08-296707b7d1bb","order_by":27,"name":"Manuel Llinás","email":"","orcid":"https://orcid.org/0000-0002-6173-5882","institution":"Pennsylvania State University","correspondingAuthor":false,"prefix":"","firstName":"Manuel","middleName":"","lastName":"Llinás","suffix":""},{"id":526461789,"identity":"d006c66f-addc-4382-a566-c832ed782282","order_by":28,"name":"Vandana Thathy","email":"","orcid":"","institution":"Columbia University Irving Medical Center","correspondingAuthor":false,"prefix":"","firstName":"Vandana","middleName":"","lastName":"Thathy","suffix":""}],"badges":[],"createdAt":"2025-09-23 20:15:10","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-7697517/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-7697517/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":93092842,"identity":"eeab4cdb-19f6-4b46-877a-118eca6024d7","added_by":"auto","created_at":"2025-10-09 02:54:05","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":1508264,"visible":true,"origin":"","legend":"","description":"","filename":"OkomboZY19489MainManuscriptmerged.pdf","url":"https://assets-eu.researchsquare.com/files/rs-7697517/v1/37f7e92ad12a4ed0723e9f24.pdf"},{"id":93092841,"identity":"b3e156d4-a48a-4f6a-acd6-f14605354529","added_by":"auto","created_at":"2025-10-09 02:54:04","extension":"json","order_by":1,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":26012,"visible":true,"origin":"","legend":"","description":"","filename":"NCOMMS2576372.json","url":"https://assets-eu.researchsquare.com/files/rs-7697517/v1/79664d8cb2cfb45b3c6c8490.json"},{"id":93092643,"identity":"06e7ecfc-73ad-40cd-bf64-c1372ae8dd87","added_by":"auto","created_at":"2025-10-09 02:53:11","extension":"docx","order_by":2,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":2667042,"visible":true,"origin":"","legend":"","description":"","filename":"OkomboZY19489SupplementaryMaterial.docx","url":"https://assets-eu.researchsquare.com/files/rs-7697517/v1/995274f254f2daa1415aa066.docx"},{"id":93093230,"identity":"fc526ab4-0435-46a1-9e8d-443079084274","added_by":"auto","created_at":"2025-10-09 02:55:37","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":1602768,"visible":true,"origin":"","legend":"Article File","description":"","filename":"OkomboZY19489MainManuscriptmerged.pdf","url":"https://assets-eu.researchsquare.com/files/rs-7697517/v1_covered_ce894f36-42fb-44f4-b099-8f72bf83095b.pdf"},{"id":93093049,"identity":"cafcc2cc-6cc1-4ec9-9133-09f740d854d4","added_by":"auto","created_at":"2025-10-09 02:54:39","extension":"docx","order_by":1,"title":"","display":"","copyAsset":false,"role":"supplement","size":2667042,"visible":true,"origin":"","legend":"Supplementary Figures and Tables","description":"","filename":"OkomboZY19489SupplementaryMaterial.docx","url":"https://assets-eu.researchsquare.com/files/rs-7697517/v1/c09bf1e3f477b91092ef3022.docx"}],"financialInterests":"There is \u003cb\u003eNO\u003c/b\u003e Competing Interest.","formattedTitle":"Collateral hypersensitivity between ZY19489 and piperaquine neutralizes PfCRT-mediated drug efflux and Plasmodium falciparum resistance","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":true,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":true,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"nature-portfolio","isNatureJournal":true,"hasQc":false,"allowDirectSubmit":false,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"","title":"Nature Portfolio","twitterHandle":"","acdcEnabled":false,"dfaEnabled":false,"editorialSystem":"ejp","reportingPortfolio":"","inReviewEnabled":true,"inReviewRevisionsEnabled":false},"keywords":"","lastPublishedDoi":"10.21203/rs.3.rs-7697517/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-7697517/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"New antimalarial drugs are essential to combat the current emergence and spread of Plasmodium falciparum parasite resistance to first-line artemisinin-based combination therapies. Here, we identify a mechanism of parasite resistance to ZY19489, a triaminopyrimidine currently in a Phase IIb clinical trial. Low-grade resistance was mediated by a novel mutation in the P. falciparum chloroquine resistance transporter PfCRT, which caused a major reduction in asexual blood stage parasite growth rates and a substantial fitness cost. Parasites resistant to ZY19489 lost their chloroquine resistance status and became hypersusceptible to the artemisinin-based combination partner drug piperaquine. All three agents were shown to interfere with parasite-mediated catabolism of host hemoglobin. Uptake studies in PfCRT-containing proteoliposomes provide evidence that ZY19489 can block mutant PfCRT-mediated efflux of piperaquine and chloroquine, creating a scenario of an evolutionary trap whereby resistance to ZY19489 blocks PfCRT efflux-mediated resistance and restores susceptibility to piperaquine and chloroquine. Metabolomic studies revealed that ZY19489 significantly reduces intracellular levels of short hemoglobin-derived peptides (a natural substrate of PfCRT) and leads to higher accumulation of pyrimidine deoxynucleotides. Our data present a marker for tracking the evolution of clinical resistance to ZY19489 and a rationale for pairing this with piperaquine to generate a novel resistance-refractory combination.","manuscriptTitle":"Collateral hypersensitivity between ZY19489 and piperaquine neutralizes PfCRT-mediated drug efflux and Plasmodium falciparum resistance","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2025-10-09 02:50:42","doi":"10.21203/rs.3.rs-7697517/v1","editorialEvents":[],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"nature-communications","isNatureJournal":true,"hasQc":false,"allowDirectSubmit":false,"externalIdentity":"NCOMMS","sideBox":"Learn more about [Nature Communications](http://www.nature.com/ncomms/)","snPcode":"","submissionUrl":"https://mts-ncomms.nature.com/","title":"Nature Communications","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"ejp","reportingPortfolio":"Nature Communications","inReviewEnabled":true,"inReviewRevisionsEnabled":false}}],"origin":"","ownerIdentity":"eb070d48-8d6b-448e-a878-614dbda6fdb6","owner":[],"postedDate":"October 9th, 2025","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"under-review","subjectAreas":[{"id":55955574,"name":"Biological sciences/Microbiology/Parasitology/Parasite biology"},{"id":55955575,"name":"Biological sciences/Chemical biology/Mechanism of action"}],"tags":[],"updatedAt":"2026-03-03T12:42:40+00:00","versionOfRecord":[],"versionCreatedAt":"2025-10-09 02:50:42","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-7697517","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-7697517","identity":"rs-7697517","version":["v1"]},"buildId":"8U1c8b4HqxoKbykW_rLl7","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00